AOD-9604 vs Exenatide

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

AOD-9604 and Exenatide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares AOD-9604 and Exenatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

AOD-9604Exenatide
CategoryWeight Management & MetabolicWeight Management & Metabolic
Regulatory status (US)Research use onlyFDA approved
Typical dosage300 mcg5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise)
FrequencydailyTwice daily (Byetta) or once weekly (Bydureon)
Reported benefitsFat metabolism, body composition improvement, no impact on blood sugar, cartilage repairGlycemic control (HbA1c reduction 0.8–1.9 percentage points), modest body weight reduction (2–4 kg), low intrinsic hypoglycemia risk, modest systolic blood pressure reduction, cardiovascular non-inferiority established in EXSCEL
Reported side effectsMinimal side effects reportedNausea, vomiting, diarrhea, injection site reactions, hypoglycemia (when co-administered with sulfonylureas), rare acute pancreatitis, rare acute kidney injury

Key differences

Primary use. AOD-9604 is categorised under Weight Management & Metabolic, while Exenatide falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. AOD-9604: not FDA-approved; treated as a research compound. Exenatide: FDA-approved.

Dosing. AOD-9604 is typically dosed at 300 mcg (daily). Exenatide is typically dosed at 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) (Twice daily (Byetta) or once weekly (Bydureon)).

Can you stack them?

Some protocols combine peptides, but stacking AOD-9604 and Exenatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between AOD-9604 and Exenatide?
AOD-9604 and Exenatide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. AOD-9604 is not FDA-approved; generally classified as a research compound, whereas Exenatide is FDA-approved for one or more indications.
What is AOD-9604 used for?
Fat loss, metabolic enhancement.
What is Exenatide used for?
FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.
Can you take AOD-9604 and Exenatide together?
Some users combine peptides within a single protocol, but stacking AOD-9604 and Exenatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is AOD-9604 or Exenatide FDA-approved?
AOD-9604 is not FDA-approved; generally classified as a research compound. Exenatide is FDA-approved for one or more indications.

Read the full articles

  • AOD-9604 — full monograph: mechanism, research, dosing & references
  • Exenatide — full monograph: mechanism, research, dosing & references

More Weight Management & Metabolic comparisons

← All peptide comparisons